MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2022 International Congress

    Asymmetry of Motor and Non-motor Signs in Parkinson’s Disease: An Exploratory Clinical Case-control Study

    F. Hansen, N. Okkels, P. Borghammer (Aarhus N, Denmark)

    Objective: To identify, quantify and correlate asymmetry between motor and non-motor signs in early Parkinson’s disease (PD). Background: Asymmetry of motor signs in PD reflects…
  • 2022 International Congress

    Resistance training in patients with Parkinson’s disease: a systematic review and meta-analysis

    R. Gollan, M. Ernst, E. Lieker, J. Caro-Valenzuela, I. Monsef, A. Dresen, M. Roheger, N. Skoetz, E. Kalbe, AK. Folkerts (Cologne, Germany)

    Objective: To analyze the effects of resistance training (RT) on motor- and non-motor outcomes in patients with Parkinson's disease (PD) compared to passive and physically…
  • 2022 International Congress

    The effect of Deep Brain Stimulation on Sense of agency in Parkinson’s disease patients with and without impulsive compulsive behaviours.

    L. Ricciardi, A. de Angelis, MP. Stenner, F. Baig, E. Pereira, S. Di Costa, MJ. Edwards, P. Haggard, F. Morgante (London, United Kingdom)

    Objective: To evaluate the effect of Deep Brain stimulation of the Subthalamic Nucleus (STN-DBS) on sense of agency in PD patients undergoing DBS; To look…
  • 2022 International Congress

    Effect of freezing of gait on the neural activity during the cognitive-motor conflict in step initiation in individuals with Parkinson’s disease: a case study

    L. de Oliveira, C. de Oliveira, P. Bazán, C. Bernardo, E. Los Angeles, M. Carvalho, J. Sato, A. de Lima-Pardini, D. Coelhodaniel, A. Baptista (Diadema, Brazil)

    Objective: To analyze the effect of freezing of gait (FoG) on the hemodynamic responses of the supplementary motor area (SMA) and dorsolateral prefrontal cortex (DLPFC)…
  • 2022 International Congress

    Effects of Virtual Reality Immersion Level on Exercise Intensity and Motivation for Persons with Parkinson Disease

    J. Palmieri, R. Gallagher, J. Donoghue, N. Volino, H. Damodaran, J. Deutsch (Newark, USA)

    Objective: The purpose of this study was to determine the effect of immersion level in virtual reality (VR) on exercise intensity and motivation for persons…
  • 2022 International Congress

    COVID-19 impact on Anxiety, Depression, Stress, and Cortisol in Persons with Parkinson’s Disease

    B. Lobb, A. Hiller (Portland, USA)

    Objective: To assess psychological stress, through subjective and objective measures, in Parkinson’s disease (PD) prior to and during the worldwide pandemic. Background: We have had…
  • 2022 International Congress

    TRPV4 Mutation related Parkinson’s Disease with Scapuloperoneal spinal muscular atrophy

    A. Deenadayalu, P. A, V. Paramanandam (Limerick, Ireland)

    Objective: Scapuloperoneal spinal muscular atrophy (SPSMA) is a rare autosomal dominant disease caused by transient receptor potential cation channel (TRPV4) gene, involving scapular and peroneal…
  • 2022 International Congress

    Exosomes from human dental pulp stem cells as a cell-free drug delivery vehicle in vitro and in vivo chronic PD rat model through the intranasal route targeting efficacy & bio-distribution.

    I. Datta, A. Kaushal, K. Mondal (Bangalore, India)

    Objective: To evaluate the drug encasement in human dental pulp stem cell derived exosomes and its delivery in vitro in single cell level using fluorescence…
  • 2022 International Congress

    The study of clonidine growth hormone study amongst definite MSA, PD, PSP, and PAF patients to assess its feasibility as a future non-invasive biomarker

    S. Bhattacharjee, E. Vichayanrat, L. Watson, V. Iodice (London, United Kingdom)

    Objective: To analyze the sensitivity and specificity of the clonidine growth hormone (CGH) to distinguish probable multiple system atrophy (MSA) from pure autonomic failure (PAF),…
  • 2022 International Congress

    CORRELATION BETWEEN OLFACTORY DYSFUNCTION AND INTENSITY OF TREMOR

    D D. Pokhabov, V. Abramov, M. Sadovsky, D V. Pokhabov (Krasnoyarsk, Russian Federation)

    Objective: Our aim was to obtain tremor data of PD and ET patients and the results of their olfactory function, which can help verify our…
  • « Previous Page
  • 1
  • …
  • 352
  • 353
  • 354
  • 355
  • 356
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley